Many pharma country affiliates face challenges in achieving an optimal resource allocation because of multiple reasons:
Opportunities in a country differ from global market situations (e.g. access).
Agility requires frequent revisions, which often leads to ‘numeric bureaucracy’.
The sum of brand level optimal resourcing can exceed affiliate level affordability.
Top-down financial resource allocation opposes empowerment of local brand teams.
Many companies have a broad and complex portfolio of brands with smaller opportunities for each, increasing resource allocation complexity.
An optimal set of infield tactics for one therapy/market is not optimal for another.
In this recorded webinar from 5 November 2024, Edouard Demeire offers a practical process with decision support tools to optimise affiliate-level resource allocation, demonstrated with case examples. By watching the recording, you will learn how to optimally:
Allocate resources in a country across brands in an agile way.
Allocate resources across tactics at brand level, ex ante and ex post.